Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1997 Nov 3;186(9):1603-8.
doi: 10.1084/jem.186.9.1603.

Prostaglandin E2 and tumor necrosis factor alpha cooperate to activate human dendritic cells: synergistic activation of interleukin 12 production

Affiliations

Prostaglandin E2 and tumor necrosis factor alpha cooperate to activate human dendritic cells: synergistic activation of interleukin 12 production

C Rieser et al. J Exp Med. .

Abstract

Interleukin (IL)-12 is a proinflammatory cytokine that contributes to innate resistance and to the development of antigen-specific T cell responses. Among other effects, prostaglandin E2 (PGE2) inhibits the production of IL-12 by macrophages activated with lipopolysaccharide (LPS). Here we investigated the effects of PGE2 on human dendritic cells (DCs) which develop in the presence of GM-CSF and IL-4. We demonstrate that in the absence of LPS, PGE2 dose dependently stimulated the production of IL-12 by DCs. Although PGE2 alone stimulated the production of low amounts of IL-12 only, it synergized with tumor necrosis factor (TNF)-alpha to induce high levels of IL-12 production by DCs. Addition of TNF-alpha in the absence of PGE2 had no effect on IL-12 production. Conversely, in the presence of LPS, PGE2 inhibited IL-12 production by DCs in a dose-dependent manner. The combination of PGE2 and TNF-alpha efficiently silenced mannose receptor-mediated endocytosis in DCs and readily induced neo-expression of the CD83 antigen. In addition, the expression of various surface antigens such as major histocompatibility complex class I and II, adhesion, as well as costimulatory molecules was upregulated by this treatment. The effects of PGE2 on IL-12 synthesis and CD83 expression could be mimicked by dibutyryl-cAMP and forskolin, indicating that they were due to the intracellular elevation of cAMP levels. DC treated with PGE2 and TNF-alpha were most potent in stimulating allogeneic T cell proliferation. Our data demonstrate that PGE2 contributes to the maturation of human DCs and that PGE2 can be a potent enhancer of IL-12 production by human DCs.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Stimulatory effects of PGE2 on IL-12 production by human DCs. Day-5 DCs were incubated with graded doses of PGE2 either alone (A) or in the presence of a constant dose of LPS (B) or TNF-α (C). Conversely, DCs were also incubated with graded doses of TNF-α in the presence of a constant dose of PGE2 (D). After 48 h of culture, supernatants were harvested and IL-12 levels were determined using a specific ELISA. Dose-dependent responses from two out of four independent experiments are shown.
Figure 2
Figure 2
Regulatory effects of PGE2 on CD83 expression and Ag uptake. (A) Day-5 DCs were incubated with PGE2 (1 μM), TNF-α (1,000 U/ml), LPS (10 ng/ml), or PGE2 plus TNF-α. After 48 h, cells were harvested and CD83 expression was measured by flow cytometry. The isotype control (IgG2b) is also presented (dotted lines). (B) Day-5 DCs were incubated with PGE2 (1 μM), TNF-α (1,000 U/ml), or PGE2 plus TNF-α. After 24 h, cells were harvested and incubated with FITC-DX for 30 min at 37°C (controls at 0°C, dotted lines), washed, and analyzed by flow cytometry.
Figure 3
Figure 3
Phenotypic changes of DCs cultured with PGE2 and TNF-α. Day-5 DCs were recultured in the absence (dotted lines) or presence of PGE2 (1 μM) plus TNF-α (1,000 U/ml) (bold lines) for 48 h and analyzed by flow cytometry for the surface expression of the indicated Ag using the antibodies listed in Materials and Methods.
Figure 4
Figure 4
Mimicry of PGE2 effects on IL-12 synthesis and CD83 expression by nonphysiologic modulators of cAMP. Day-5 DCs were incubated with db-cAMP (100 μM) or forskolin (10 μM) either alone or in combination with TNF-α (1,000 U/ml). After 48 h, supernatants were analyzed for the presence of IL-12 using a specific ELISA (A) and the cells were analyzed for CD83 expression by flow cytometry (B). Data are given as mean ± SEM of four independent experiments.
Figure 5
Figure 5
T cell stimulatory capacity of DCs cultured with PGE2. Day-5 DCs were recultured in the absence or presence of PGE2 (10 μM), TNF-α (1,000 U/ml), or PGE2 plus TNF-α. After 48 h the cells were washed, irradiated, and DCs were used as stimulators of allogeneic T cell proliferation. Proliferation was monitored by measuring [methyl-3H]thymidine uptake on day 5 of coculture. Each value represents the mean cpm of triplicate cultures with SD.

References

    1. Fearon DT, Locksley RM. The instructive role of innate immunity in the acquired immune response. Science (Wash DC) 1996;272:50–53. - PubMed
    1. Portanova JP, Zhang Y, Anderson GD, Hauser SD, Masferrer JL, Seibert K, Gregory SA, Isakson PC. Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo. J Exp Med. 1996;184:883–891. - PMC - PubMed
    1. Garrison, J.C. 1990. Histamin, bradykinin, 5-hydroxytryptamine and their antagonists. In The Pharmacological Basis of Therapeutics. A. Gilman, T.W. Rall, A.S. Nies, and P. Taylor, editors. Pergamon Press, New York. 574–599.
    1. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109–142. - PubMed
    1. Vane, J.R., and R.M. Botting. 1994. Biological properties of cyclooxygenase products. In The Handbook of Immunopharmacology. F.M. Cunningham, editor. Academic Press, London. 61–97.

Publication types

MeSH terms